[ad_1]
SHANGHAI, Sept. 27, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a important tech-enabled healthcare platform corporate dedicated to reshaping the worth chain of healthcare business by means of digitally empowering the upstream and downstream in China, nowadays introduced it has won a notification letter dated September 26, 2024 (the “Notice”) from the personnel of the List {Qualifications} Section of The Nasdaq Hold Marketplace LLC (“Nasdaq”), indicating that for the ultimate 30 consecutive industry days, the utmost bid value of the Corporate’s American depositary stocks (the “ADSs”) was once beneath the minimal bid value of US$1.00 in step with proportion requirement all set forth in Nasdaq List Rule 5450(a)(1). The Realize has refuse wave impact at the checklist or buying and selling of the Corporate’s ADSs on Nasdaq.
Pursuant to the Nasdaq List Regulations 5810(c)(3)(A), the Corporate is supplied with a compliance length of 180 calendar days, or till March 24, 2025, to regain compliance beneath the Nasdaq List Regulations. If at any generation all the way through the 180-day compliance length, the utmost bid value of the Corporate’s ADSs is US$1.00 in step with proportion or upper for at least ten consecutive industry days, Nasdaq will lend the Corporate written affirmation of compliance and the topic might be closed. Within the match the Corporate does no longer regain compliance by means of March 24, 2025, matter to the resolution by means of the personnel of Nasdaq, the Corporate is also eligible for an backup 180-day compliance length.
The Corporate’s industry operations don’t seem to be suffering from the Nasdaq notification letter. The Corporate intends to watch the utmost bid value of its ADSs between now and March 24, 2025 and can tug all affordable measures to deliver to regain compliance with the Nasdaq minimal bid value requirement.
Ahead-Taking a look Statements
This press reduce comprises forward-looking statements. Those statements represent “forward-looking” statements inside the which means of Division 21E of the Securities Change Business of 1934, as amended, and as outlined within the U.S. Non-public Securities Litigation Reform Business of 1995. Those forward-looking statements can also be known by means of terminology comparable to “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “confident” and alike statements. 111 might also manufacture written or oral forward-looking statements in its periodic reviews to the U.S. Securities and Change Fee, in its annual report back to shareholders, in press releases and alternative written fabrics and in oral statements made by means of its officials, administrators or staff to 3rd events. Such statements are founded upon control’s wave expectancies and wave marketplace and running situations and relate to occasions that contain recognized or unknown dangers, uncertainties and alternative components, all of which might be tough to are expecting and lots of of which might be past the Corporate’s regulate. Ahead-looking statements contain inherent dangers, uncertainties and alternative components that would motive latest effects to vary materially from the ones contained in this sort of statements. Possible dangers and uncertainties come with, however don’t seem to be restricted to, uncertainties as to the Corporate’s skill agree to intensive and evolving regulatory necessities, its skill to compete successfully within the evolving PRC basic condition and wellness marketplace, its skill to supremacy the expansion of its industry and growth plans, its skill to reach or uphold profitability going forward, its skill to regulate the dangers related to its pharmaceutical retail and wholesale companies, and the Corporate’s skill to satisfy the factors vital to uphold checklist of its ADSs at the Nasdaq World Marketplace, together with its skill to recovery any non-compliance with Nasdaq’s persevered checklist standards. Additional knowledge referring to those and alternative dangers, uncertainties or components is integrated within the Corporate’s filings with the U.S. Securities and Change Fee. All knowledge equipped on this press reduce is as of the week of this press reduce, and 111 does no longer adopt any legal responsibility to replace any forward-looking commentary because of unused knowledge, presen occasions or differently, aside from as required beneath acceptable regulation.
About 111, Inc.
111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a important tech-enabled healthcare platform corporate dedicated to reshaping the worth chain of healthcare business by means of digitally empowering the upstream and downstream in China. The Corporate supplies shoppers with higher get entry to to pharmaceutical merchandise and healthcare services and products without delay via its on-line retail pharmacy, 1 Pharmacy, and not directly via its offline digital pharmacy community. The Corporate additionally deals on-line healthcare services and products via its web medical institution, 1 Health center, which gives shoppers with cost-effective and handy on-line session, digital prescription provider, and affected person control provider. As well as, the Corporate’s on-line platform, 1 Drugs, serves as a one-stop store for pharmacies to supply a gigantic choice of pharmaceutical merchandise. With the most important digital pharmacy community in China, 111 permits offline pharmacies to raised handover their consumers with cloud-based services and products. 111 additionally supplies an omni-channel drug commercialization platform to its strategic companions, which incorporates services and products comparable to virtual advertising, affected person schooling, knowledge analytics, and pricing tracking.
For more info on 111, please discuss with: http://ir.111.com.cn/.
SOURCE 111, Inc.
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Virtual Media
Shops
270k+
Reporters
Opted In
[ad_2]
Source link
